Status:
UNKNOWN
AUSTrian Randomized Interventional Study on Dialysis Accesses
Lead Sponsor:
Medical University of Vienna
Conditions:
End Stage Renal Disease
Catheter Infection
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Patients with diagnosed end stage renal disease and indication for chronic dialysis rely on a well-functioning access for dialysis. The KDOQI Guidelines For Vascular Access follows a "fistula first" a...
Eligibility Criteria
Inclusion
- Age of 60 and higher
- CCI Score \>6 when under 60 years
- Patients with CKD G5 A1-3 with indication for hemodialysis
- Stable clinical condition
- Eligibility for both arteriovenous fistula on the upper extremitiesandTCC
- Availability for follow-up.
- Written informed consent.
Exclusion
- Uncontrolled infection at screening and/or CRP \>5 mg/dl (normal \<0.5 mg/dl) at screening.
- Poor general condition of health or malignancy not in remission at screening
- Major surgery within 12 weeks before screening.
- Pre-existent vascular access.
- Patient not eligible for any one of the vascular access options.
Key Trial Info
Start Date :
March 6 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 4 2022
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT03764358
Start Date
March 6 2019
End Date
October 4 2022
Last Update
December 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Medicine III, Devision of Nephrology and Dialysis, Medical University of Vienna
Vienna, Austria, 1090